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Abstract
Background: It is widely accepted the key role of endothelium in the onset of many chronic and acute vascular
and cardiovascular diseases.
In the last decade, traditional compounds utilized in “folk medicine” were considered with increasing interest to
discover new bioactive molecules potentially effective in a wide range of diseases including cardiovascular ones.
Since ancient times different parts of the Cucumis sativus L. plant were utilized in Ayurvedic medicine, among these,
fruits were traditionally used to alleviate skin problem such as sunburn irritation and inflammation. The main purpose
of the present research was, in a well-defined in vitro model of endothelial cells, to investigate whether a water/
ethanol extract of Cucumis sativus L. (CSE) fruit can attenuate the damaging effect of pro-inflammatory lipopolysaccharide
(LPS).
Methods: Cell viability, gene expression of endothelial cell markers, cytokines secretion and in vitro angiogenesis assay
were performed on porcine Aortic Endothelial Cells exposed to increasing doses (0.02; 02; 2 mg/ml) of CSE in the
presence of pro-inflammatory lipopolysaccharide (LPS 10 μg/ml).
Results: CSE reduced LPS-induced cytotoxicity and decreased the cellular detachment, restoring the expression of
tight junction ZO-1. The increase of TLR4 expression induced by LPS was counterbalanced by the presence of CSE,
while the protective gene Hemeoxygenase (HO)-1 was increased. Cucumis sativus L. inhibited the early robust secretion
of inflammatory IL-8 and GM-CSFs, furthermore inhibition of inflammatory IL-6 and IL-1α occurred late at 7 and 24 h
respectively. On the contrary, the secretion of anti-inflammatory IL-10, together with IL-18 and IFN-γ was increased.
Moreover, the in vitro angiogenesis induced by inflammatory LPS was prevented by the presence of Cucunis sativus L.
extract, at any doses tested.
Conclusions: Our results have clearly demonstrated that Cucumis sativus L. extract has attenuated lipopolysaccharide-
induced inflammatory response in endothelial cells.
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Background
Vascular integrity contributes to the maintenance of the
homeostasis of the whole organism [1]. The break of the
vascular balance causes many pathological alterations,
including cardiovascular diseases (CDVs), that represent
the principle cause of death globally [2].
Among vascular cellular components, endothelial cells
(EC) establish the inner lining of blood vessels and
perform a pivotal role in the maintenance of the vascular
integrity [1, 3–5]. Moreover endothelial cells have a key
position in the beginning, progression, control and reso-
lution of the vascular dysfunction [6–9]. Several en-
dogenous and exogenous pro-inflammatory stimuli, such
as lipopolysaccharide (LPS), induce “EC activation”. The
phenotype of activated endothelial cells promotes phenom-
ena of vasoconstriction, leukocyte adhesion, coagulation
and thrombosis. This change involves the up-regulation of
pro-inflammatory genes, including secretion of inflamma-
tory cytokines and chemokines. If the pro-inflammatory
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status is not counterbalanced by the synthesis of pro-
tective molecules, the endothelial activation converts
into the endothelial dysfunction and then in the vas-
cular disease [10, 11].
In full accordance with the principle of “Replacement”,
one of the commonly-accepted 3Rs rules (Replacement,
Reduction and Refinement) for more ethical use of ani-
mals in experimental testing, primary culture of porcine
Aortic Endothelial Cells (pAECs) were successfully used
in many different in vitro models, preceding the in vivo,
confirming swine as a relevant animal model for transla-
tional medicine [12–17].
In the last decade, traditional compounds utilized in
“folk medicine” have been considered with increasing
interest to discover new bioactive molecules potentially ef-
fective in a wide range of diseases including cardiovascular
ones. Nevertheless, to support the traditional medicine use
of these compounds, scientific informations regarding the
phytochemical or biological activity are needed. [18, 19].
Cucumber (Cucumis sativus L.) is a popular vegetable
crop member of the Cucurbitaceae family commonly
cultivated for its edible fruits. Since ancient times, differ-
ent parts of the cucumber plant have been employed in
Ayurvedic medicine, among these, fruits are traditionally
used to alleviate skin problem such as sunburn’s irrita-
tion and inflammation [20, 21]. Recently in vitro evi-
dences [22] suggested that a Cucumis sativus extract
show strong anti-oxidant capacity and ability to stability
the membrane of human red blood. Moreover, Patil [23]
demonstrated that aqueous extracts of Cucumis sativus
is efficacious on inflammatory model of ulcerative colitis
in in vivo model of Wister rats.
Nowadays no studies have investigated the effect of
Cucumis sativus L. on vascular endothelial cells. There-
fore, to provide new scientific evidence to support trad-
itional medicine use of Cucumis sativus L., the main
purpose of the present research was to investigate
whether a water/ethanol extract of Cucumis sativus L.
fruit (CSE) can attenuate the deleterious effects of LPS
in in vitro model of endothelial cells.
Methods
Chemicals and reagents
Human endothelial SFM medium, heat inactivated FBS
(Fetal Bovine Serum), antibiotic-antimycotic and Dulbec-
co’s phosphate buffered saline (DPBS) were purchased
from Gibco-Life technologies (Carlsbad CA, USA).
RNA isolation was performed with NucleoSpin RNA kit
(Macherey-Nagel GmbH & Co. KG, Düren Germany),
iScript cDNA synthesis kit and iTaq Universal SYBR
Green Supermix were used for cDNA synthesis and qPCR
analysis (Bio-Rad Laboratories Inc., Hercules, CA, USA).
All plastic supports were purchased from Falcon,
Beckton-Dickinson.
A water/ethanol extract of Cucumis sativus L. fruit
(CSE), titrated for total iminosugar acids content by
HPLC-MS (2 g/100g), was kindly provided by Naturalea
(Naturalea SA, Lugano, CH - Cuvrex batch number
CE1501).
Cell culture
Porcine Aortic Endothelial Cells (pAECs) were isolated
and maintained as previously described by Bernardini
and colleagues [12]. Briefly thoracic aortic traits were
collected in a local slaughterhouse from adult pigs. After
collection, thoracic aortic traits were washed with DPBS,
ligated at the ends, and transferred to the laboratory
within 1 h on ice. After ligation of all arterial side
branches, aortas were cannulated with modified syringe
cones and silicone tubes to set up a closed system. The
vessels were repeatedly flushed with DPBS and then
filled with a collagenase solution and incubated for
20 min at 37 °C. The cellular sospension were then cen-
trifuged at 800 x g for 10 min. The cellular pellet was re-
suspended in 1 mL human endothelial basal growth
medium (Gibco-Invitrogen, Paisley, UK) supplemented
with 5% fetal bovine serum (Gibco-Invitrogen) and 1%
antibiotics-antimicotics (Gibco-Invitrogen). Cell number
and viability (85–90%) were determined using a Burker
chamber under a phase-contrast microscope after vital
staining with trypan blue dye. Cells were maintained in a
logarithmic growth phase by routine passages every 2–
3 days at a 1:3 split ratio. To confirm their endothelial
origin, cultured cells were checked by immunocitochem-
istry for endothelial cell markers: CD31 and Caderine.
Then cells were expanded till 20th passages. All experi-
ments were performed with cells from the third to the
eighth passage. The first seeding after thawing was al-
ways performed in T-25 tissue culture flasks (3 × 105
cells/flask) and successive experiments were conducted
in 24-well plates (qPCR and western blot analysis), in
96-well assay plates (cytotoxicity) and 8-well slide cham-
ber for in vitro angiogenesis assay. Cells were cultured
in Human endothelial SFM medium, added with FBS
(5%) and antimicrobial/antimycotic solution (1×) in a 5%
CO2 atmosphere at 38.5 °C.
Cytotoxicity
Since the non-toxicity of the extract is a fundamental
pre-requisite, we first tested the cytotoxicity of the CSE
in a concentration range of 0.0002–2 mg / ml. No tox-
icity was showed at any doses tested.
pAECs were seeded in a 96 wells plate (approximately
3 × 103 cells/well) and exposed to increasing doses of
Cucumis sativus L. (CSE) (0.02; 0.2; 2 mg/ml) in pres-
ence of lipopolysaccharide (LPS) (10 μg/ml) (E. coli
055:B5, Sigma-Aldrich Co, St Louis, MO, USA) for 24 h.
Cytotoxicity was evaluated by trypan Blue exclusion dye
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using Countess® II FL Automated Cell Counter (Life
Technologies).
Quantitative real time PCR for ZO-1, TLR4, HO-1
pAECs were seeded in a 24 wells plate (approximately
4 × 104 cells/well) and exposed to increasing doses (0.02;
0.2; 2 mg/ml) of CSE in presence of LPS (10 μg/ml) for
1, 7 and 24 h. At the end of experimental times, treated
or control cells were collected and stored until gene ex-
pression analysis.
Total RNA was isolated using the NucleoSpin®RNA
Kit, and high quality RNA, with A260/A280 ratio above
2.0 was used for cDNA synthesis. Total RNA (500 ng)
was reverse-transcribed to cDNA using the iScript
cDNA Synthesis Kit in a final volume of 20 μL. Swine
primers were designed using Beacon Designer 2.07
(Premier Biosoft International, Palo Alto, CA, USA). Pri-
mer sequences, expected PCR product lengths and ac-
cession numbers in the NCBI database are shown in
Table 1.
Quantitative real-time PCR was performed to evaluate
gene expression profiles in CFX96 (Bio-Rad) thermal cy-
cler using SYBR green detection system. A master mix
of the following reaction components was prepared in
nuclease free water to the final concentrations indicated:
0.2 μM forward primer, 0.2 μM reverse primer, 1X iTaq
Universal SYBR Green Supermix. One μl of cDNA was
added to 19 μl of the master mix. All samples were ana-
lyzed in duplicate. The qPCR protocol used was: 10 min
at 95 °C, 40 cycles at 95 °C for 15 s and at 61 °C for
30 s, followed by a melting step from 55 °C to 95 °C
(80 cycle of 0.5 °C increase/cycle).
The expression level of interest genes was calculated
as fold of change using the 2-ΔΔCT method [24].
Western blot for TLR4 and HO-1
pAECs were seeded in a 24 wells plate (approximately
4 × 104 cells/well) and exposed to increasing doses (0.02;
0.2; 2 mg/ml) of CSE for 24 h. At the end of experimen-
tal time, cells were harvested and lysed in SDS solution
(Tris–HCl 50 mM pH 6.8; SDS 2%; glycerol 5%). Protein
Assay Kit (TP0300, Sigma) was used to determine the
protein content of cellular lysates. Aliquots containing
20 μg of proteins were separated on NuPage 4–12%
bis-Tris Gel (Gibco-Life-Technologies) for 50 min at
200 V. The proteins were then electrophoretically
transferred onto a nitrocellulose membrane by Turbo Blot
System (Bio-Rad). The blots were washed in PBS and pro-
tein transfer was checked by staining the nitro-cellulose
membranes with 0.2% Ponceau Red. Non-specific binding
on nitrocellulose membranes was blocked with 5% milk
powder in PBS-T20 (Phosphate Buffer Saline-0.1%
Tween-20) for 1 h at room temperature. The membranes
were then incubated over-night at 4 °C with a 1:500 dilu-
tion of anti-HO-1 rabbit polyclonal antibody (SPA 896
StressGen Biotecnologies Corp, Victoria BC, Canada) and
1:1000 anti TLR4 mouse monoclonal antibody (NB100–
56566 Novus Biologicals, Littleton, CO, USA). After sev-
eral washings with PBS-T20, the membranes were incu-
bated with the secondary biotin-conjugate antibody and
then with a 1:1000 dilution of an anti-biotin horseradish
peroxidase (HRP)-linked antibody.
The western blots were developed using chemilumines-
cent substrate (Super Signal West Pico Chemiluminescent
Substrate, Pierce Biotechnology, Inc., Rockford, IL, USA)
according to the manufacturer’s instructions. Chemidoc
instrument using Quantity One Software (Bio-Rad) ac-
quired the intensity of the luminescent signal of the result-
ant bands.
In order to normalize the HO-1 and TLR4 data on the
housekeeping protein, membranes were stripped (briefly:
the membranes were washed 5 min in water, then 5 min
in 0.2 M NaOH and then washed again in water) and
re-probed for housekeeping α-tubulin (1:500 of anti
α-tubulin MA1–19162, Thermo Fisher Scientific, Rock-
ford, IL, USA).
The relative protein content (HO-1 or TLR4/α-tubu-
lin) was expressed as arbitrary units (AUs).
Multiparametric enzyme-linked immunosorbent assay
(ELISA) for cytokines and chemokines
Concentration of 13 cytokines and chemokines (GM-CSF,
IFN-γ, IL-1α, IL-1β, IL-1ra, IL-2, IL-4, IL-6, IL-8, IL-10,
IL-12, IL-18, TNF-α) was measured by quantitative multi-
parametric ELISA (Enzyme-linked immunosorbent assay).
(Porcine Cytokine/Chemokine Magnetic Bead Panel kit,
Milliplex Map Kit, EMD Millipore Corporation, Billerica
MA USA), following the manufacturer’s instructions. The
Luminex xMAP bead-based multiplexed immunoassay
technology and MAGPIX instrument provided with xPO-
NENT 4.2 software were used.
Table 1 Primer sequence used for quantitative Real Time PCR analysis
Genes Forward (5′-3′) Reverse (5′-3′) Product size (bp) Accession Number
HPRT GGACAGGACTGAACGGCTTG GTAATCCAGCAGGTCAGCAAAG 115 AF143818
HO-1 CGCTCCCGAATGAACAC GCTCCTGCACCTCCTC 112 NM_001004027
TLR4 CAGATACAGAGGGTCATGCTTTC GGGGATGTTGTCAGGGATTTG 215 NM_001113039.1
ZO-1 AGTGCCGCCTCCTGAGTTTG CATCCTCATCTTCATCATCTTCTACAG 147 AJ318101
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Capillary-like tube formation assay
The experiments were carried out using 8-well slide
chamber (BD Falcon Bedford, MA USA) coated with un-
diluted Geltrex™ LDEV-Free Reduced Growth Factor
Basement Membrane Matrix. Extracellular matrix coat-
ing was carried out for 3 h in a humidified incubator, at
38.5 °C, 5% CO2. pAECs (8 × 10
4 cells/well) were ex-
posed to increasing doses (0.02; 0.2; 2 mg/ml) of (CSE)
in the presence of LPS (10 μg/ml) for 24 h.
At the end of experimental time, images were acquired
using a digital camera installed on a Nikon epifluores-
cence microscope (Nikon, Yokohama, Japan) and ana-
lyzed by open software Image J 64.
Statistical analysis
Each treatment was replicated three times or six times
(cytotoxicity) in three independent experiments. The
data were analysed by a one-way analysis of variance
(ANOVA) followed by the Tukey post hoc comparison
Test. Differences of at least p < 0.05 were considered sig-
nificant. Statistical analysis was carried out by using R
software (http://www.R-project.org) [25].
Results
CSE prevented LPS-induced cell death and ZO-1 reduction
The protective effect of Cucumis sativus L. extract on
LPS-induced toxicity was evaluated in pAECs. LPS treat-
ment provoked an increased number of round and de-
tached cells after 24 h (Fig. 1a), while CSE reduced the
cellular detachment in a dose dependent manner (Fig.
1b-d). Cytotoxicity assay confirmed the ability of CSE to
protect cells against LPS-induced cellular death (Fig. 1e).
Moreover, we studied the expression of ZO-1, a critical
component of tight junction scaffold; LPS induced the
downregulation of ZO-1 gene expression, while CSE re-
stored ZO-1 expression to control level at the intermedi-
ate and higher doses (Fig. 1f ).
Effect of CSE on TLR-4 and HO-1 expression
We studied the effect of CSE on the expression of the
Toll-like receptor 4 (TLR4) that is the main receptor for
LPS recognition. LPS induced a significant increase of
TLR4 mRNA after 1 and 7 h of treatment, while CSE
inhibited its expression at all doses studied (Fig. 2a).
This inhibitory effect was confirmed at protein level by
western blot analysis as shown in Fig. 2b and c. More-
over, we studied the effect of CSE on the vascular pro-
tective molecule HO-1. LPS induced HO-1 expression in
pAECs, additionally CSE increased HO-1 induction at
both mRNA (Fig. 3a) and protein level (Fig. 3b and c).
Effect of CSE on cytokine/chemokines secretion
To assess whether CSE could influence the LPS-induced
secretion of inflammatory mediators we evaluated the
presence of 13 cytokines/chemokines in the culture
medium of pAECs treated with LPS in the presence or
absence of CSE (2 mg/ml). LPS-treated endothelial cells
released significant level of Il-6, Il-8, IL-10, IL-18,
GM-CSF and IFN-γ. CSE significantly influenced these
cytokines setting; in particular, the presence of the ex-
tract decreased the concentration of GM-CSF, IL-8 and
IL-1α with a different kinetic, whereas the concentration
Fig. 1 Effect of Cucumis sativus L. extract (CSE) on LPS-induced pAECs
toxicity. a Representative images of pAECs morphology under LPS
(10 μg/ml) stimulation (b, c, d) and in the presence of increasing dose
of CSE (0.02; 0.2; 2 mg/ml). e Protective effect of CSE on LPS-induced
cytotoxicity; data shown are representative of at least three
independent experiments and represent the mean ± SEM. f CSE
restored the LPS-induced decrease of ZO-1 mRNA expression;
relative expression was calculated as fold of change in respect
to the control cells and error bar represents the range of relative gene
expression. Different letters above the bars indicate significant
differences (p < 0.05 ANOVA post hoc Tukey’s test)
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of IL-10, IL-18 and IFN-γ was increased at each experi-
mental point, as shown in Table 2. The level of IL-6
showed a precocious increase (1 h) in presence of CSE
but after 7 and 24 h, cells treated with plant extract pro-
duced less IL-6 than cells only treated with LPS. IL-1β,
IL-1ra, IL-2, IL-4, IL-12 and TNF-α were never detected
in cell culture medium (data not shown).
Effect of CSE on LPS-induced angiogenesis
We examined the effect of CSE on in vitro LPS-induced
pAECs angiogenesis in an extracellular matrix-based
assay. Cells cultured on extracellular matrix in the pres-
ence of pro-inflammatory LPS assembled in a complete
tube and network formation (Fig. 4a and e), while the in
vitro angiogenesis induced by inflammatory LPS was
prevented by the presence of Cucunis sativus L. extract,
at any doses tested (Fig. 4b-e).
Discussion
It is widely accepted the key role of endothelium in the
onset of many chronic and acute vascular and cardiovas-
cular diseases. The shift from the healthy endothelium
to the endothelial dysfunction is a complex process
involving many different factors that starts with “the ac-
tivation of endothelial cells”.
Recently, great effort is attempted to translate the poten-
tial activity of traditional compounds into the modern
therapy, in a broad range of pathologies including cardio-
vascular disease [18]. Cucumis sativus L. is a very popular
vegetable, native of India but nowadays commercially cul-
tivated all over the world. Furthermore, since ancient time,
Ayurvedic medicine has always used its fruits and seeds
for their refrigerant, haemostatic tonic properties. It is
now evident that fruits contain many interesting
phyto-complex [20, 26] that makes it an interesting
candidate for anti oxidant [27] and anti-inflammatory
action [28] but the study of their effect still requires
scientific supports.
The present study demonstrates that the protective ef-
fects reported for Cucumis sativus L., might be also medi-
ated by its protective activity on the vascular endothelium.
Being the pig an excellent model for translational re-
searches [29], in vitro approaches based on primary cell
culture are required to better define the subsequent
eventual in vivo activities to respect the 3Rs rules. We
used in vitro cultures of porcine Aortic Endothelial Cells
Fig. 2 Effect of Cucumis sativus L. extract (CSE) on LPS induced TLR4 expression. a Expression of TLR4 mRNA in pAECs treated with LPS (10 μg/ml)
for different time (1, 7, 24 h) in the presence or absence of increasing doses of CSE (0.02; 0.2; 2 mg/ml). mRNA expression of TLR4 is determined by
quantitative PCR; relative expression was calculated as fold of change in respect to the control cells and error bar represents the range of relative
expression. Different letters above the bars indicate significant differences. b Representative Western Blot of TLR4 and relative housekeeping α-tubulin
were reported. c Expression of TLR4 protein in pAECs treated with LPS (10 μg/ml) in the presence or absence of increasing doses CSE (0.02; 0.2; 2 mg/
ml); data shown are representative of at least three independent experiments and represent the mean ± SEM. Different letters above the bars indicate
significant differences (p < 0.05 ANOVA post hoc Tukey’s test)
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(pAECs), previously isolated and cultured by us to study
vascular endothelial response to different shock, includ-
ing LPS [12, 13, 30].
In the present research, LPS-induced effects on pAECs
is contrasted by the contemporary administration of
Cucumis sativus L. extract; in fact CSE protected endo-
thelial cells against LPS-induced toxicity, in a dose
dependent manner. Furthermore LPS reduced the ex-
pression of the tight junction molecule ZO-1, increasing
the number of round and detached cells. Instead,
Cucumis sativus L. extract, restored the ZO-1 expres-
sion, contributing to maintain the integrity of cellular
tight junction, as confirmed by the reduction of cellular
detachment.
It is well demonstrated that the exposure to LPS in-
duces endothelial cell activation through the binding of
a receptor complex that includes TLR4 [31–34]. In our
model TLR4 expression is increased by LPS making cells
more responsive to the stimulation, according to what
seen by other researchers [35, 36]. In contrast, the
Fig. 3 Effect of Cucumis sativus L. extract (CSE) on LPS induced HO-1 expression. a Expression of HO-1 mRNA in pAECs treated with LPS (10 μg/
ml) in the presence or absence of increasing doses of Cucumis sativus L. extract (0.02, 0.2, 2 mg/ml). mRNA expression of HO-1 as determined by
quantitative PCR. Relative expression was calculated as fold of change in respect to the control cells and error bar represents the range of relative
gene expression. Different letters above the bars indicate significant differences. b Representative Western Blot of HO-1 and relative housekeeping
α-tubulin were reported. c Expression of HO-1 protein in pAECs treated with LPS (10 μg/ml) in the presence or absence of increasing doses CSE (0.02;
0.2; 2 mg/ml); data shown are representative of at least three independent experiments and represent the mean ± SEM. (AU = Arbitrary Units) Different
letters above the bars indicate significant differences (p < 0.05 ANOVA post hoc Tukey’s test)
Table 2 Levels of cytokines/chemokines in culture medium of pAECs stimulated with LPS (10 μg/ml) in the presence or absence of
Cucumis sativus L. extract (CSE 2 mg/ml). Data shown are representative of at least three independent experiments and represent
the mean ± SEM. Significant differences are indicated by (p < 0.05) *, and (p < 0.001) by ** nd not detectable
ng/ml 1 h 7 h 24 h
CSE-/LPS+ CSE+/LPS+ CSE-/LPS+ CSE+/LPS+ CSE-/LPS+ CSE+/LPS+
IL-1α nd nd nd nd 0.0592 ± 0.0019 0.0140 ± 00002**
IL-6 nd 0.1574 ± 0.0064 4.3163 ± 0.0893 3.3889 ± 0.0835* 8.0129 ± 0.3067 3.9270 ± 0.0335**
IL-8 6.3445 ± 0.4821 2.3809 ± 0.0434** > 50 24.2300 ± 2.2100 31.5600 ± 3.8210* 25.1500 ± 2.7210
IL-10 0.0077 ± 0.0023 0.0355 ± 0.0010** 0.0187 ± 0.0025 0.0395 ± 0.0034* 0.0209 ± 00017 0.0400 ± 0.0056**
IL-18 0.0319 ± 0.0021 0.1796 ± 0.0049** 0.0572 ± 0.0011 0.1897 ± 0.0033** 0.0606 ± 0.0034 0.1913 ± 0.0056**
GM-CSF 0.1083 ± 0.0071 nd 0.1895 ± 0.0221 nd 0.2061 ± 0.0094 0.0021 ± 0.0037**
IFN-γ 0.0501 ± 0.0436 1.5529 ± 0.0292** 0.2654 ± 0.0889 0.5230 ± 0.0725* 0.0725 ± 0.0378 0.3522 ± 0.0340**
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presence of Cucumis sativus L. extract, inhibited the
LPS-induced expression of TLR4.
The inflammatory signalling driven by TLR4 in
endothelial cells goes through the activation of NF-κB
and the consequently induction or shutdown of sev-
eral genes including those for cytokines/chemokines
synthesis [37].
The presence of CSE in the culture medium con-
trasted early the robust secretion of inflammatory IL-8
and GM-CSFs; while inhibition of inflammatory IL-6
and IL-1α occurred late at 7 and 24 h respectively. On
the contrary, the anti-inflammatory IL-10 is increased
together with IL-18 and IFN-γ.
Since the production and function of cytokines overlaps,
what is the meaning of our results? Considering that in
vivo endothelial cells mainly produce IL-6 and IL-8 and
being, among the major functions of these cytokines, the
induction of angiogenesis [11], the anti-angiogenic effect
of CSE, evidenced by the in vitro-angiogenesis assay, is in
agreement with the inhibition of these cytokines. More-
over interleukin 18 (IL-18), firstly described as a novel
cytokine that stimulates interferon-γ (IFN-γ) production,
possessed potent antitumor effects achieved by the inhib-
ition of angiogenesis in vivo [38], so the increase of IL-18
in our model, could also contribute to a reduction in in-
flammatory angiogenesis.
Overall, our results demonstrate that the extract of
Cucumis sativus L. influenced the secretion of cyto-
kines/chemokines trough the reduction of TLR4 expres-
sion; moreover, the effect of this modulation inhibited
the inflammation-induced angiogenesis. Overall, these
important results suggest that Cucumis sativus L. extract
could be a very interesting candidate in counteracting
inflammatory pathologies in which TLR play a crucial
modulatory role.
Furthermore, to avoid that the endothelial cell activa-
tion results in dysfunction, the induction of protective
genes must be strictly regulated. Among protective
genes, Hemeoxygenase (HO)-1, the rate-limiting enzyme
in the heme catabolism, has been demonstrated to
present important beneficial roles in the vasculature
[39]; in particular HO-1 exerts antiapoptotic, antioxi-
dants, antithrombotic and anti-atherogenic effects [39].
Our previous reports showed the LPS ability to induce
HO-1 expression [12]; in the present research we dem-
onstrated that Cucumis sativus L. extract increased the
expression of vascular protective HO-1. Moreover, the
role of HO-1 in angiogenesis is intriguing in fact HO-1
activity is necessary for VEGF-induced angiogenesis,
whereas HO-1 has the opposite effect in the pathological
angiogenesis [39]. Therefore, in our model, the increase
of HO-1 could exert protective effect including the in-
hibition of LPS-induced inflammatory angiogenesis.
Conclusions
Our results demonstrate the efficacy of a water/ethanol ex-
tract of Cucumis sativus L. fruit to protect vascular endo-
thelial cells against LPS-challenge: decreasing LPS-induced
TLR4 expression, influencing cytokines secretion, in-
creasing the expression of protective HO-1. Moreover,
the presence of Cucumis sativus L. extract inhibited the
LPS-induced cellular toxicity and inflammation-induced
angiogenesis. These impressive and robust results propose
the Cucumis sativus L. extract as a promising natural
compound in vascular endothelium protection.
Fig. 4 Effect of Cucumis sativus L. extract on LPS-induced angiogenesis. pAECs were cultured on a extracellular matrix with LPS (10 μg/ml) in the
absence (a) or presence of increasing doses (0.02; 0.2; 2 mg/ml) of Cucumis sativus L. extract (b, c, d respectively) for 18 h. LPS induced a capillary
like network (a, e) while CSE reduced LPS-induced angiogenesis at any doses tested (b-e). Data shown are representative of at least three independent
experiments and represent the mean ± SEM. Different letters above the bars indicate significant differences (p < 0.05 ANOVA post hoc Tukey’s test)
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